Mupirocin is used for
Mupirocin inhibits bacterial RNA and protein synthesis. It is only available as a 2% topical preparation which is bactericidal against staphylococci and ?-hemolytic streptococci. Systemic absorption of topical mupirocin is negligible. Mupirocin is used for impetigo (impetigo and ecthyma) Minor superficial secondary infected skin lesions elimination of Staphylococcus aureus in nasal colonization, although there are often recurrences Continued treatment leads to mupirocin-resistant staphylococci. Mupirocin is not toxic but can cause when used on bare skin or mucosal itching and burning.